Evidence map›Paper›PMID 42414784›Full record

ArticleLa Radiologia medica2026

Request and reporting models for computed tomography in the multidisciplinary management of cancer patients: consensus between the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Medical Oncology (AIOM).

Vincenza Granata, Alessandro Serafini, Roberta Fusco, Damiano Caruso, Ginevra Danti, Iliana Bednarova, Nerina Derano, Emilio Bria, Lorena Incorvaia, Luca Moscetti and 30 more

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Vincenza GranataDivision of Radiology, "Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli", Naples, Italy.
Alessandro SerafiniDepartement of Radiology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. alessandro.serafini@ircc.it.ORCID http://orcid.org/0000-0002-4992-4824
Roberta FuscoDivision of Radiology, "Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli", Naples, Italy.
Damiano CarusoDepartment of Medical Surgical Sciences and Translational Medicine, Sapienza-University of Rome, Radiology Unit-Sant'Andrea University Hospital, 00189, Rome, Italy.
Ginevra DantiDepartement of Radiology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Iliana BednarovaRadiology Unit, Veneto Institute of Oncology, IRCCS, Padua, Italy.
Nerina DeranoMedical Oncology Division, Fondazione IRCCS Ca'Grande Ospedale Maggiore Policlinico, Milan, Italy.
Emilio BriaUniversità Cattolica del Sacro Cuore, Ospedale Isola Tiberina - Gemelli Isola, Rome, Italy.
Lorena IncorvaiaDepartement of Precision Medicine in Medical, Surgical and Critical Care, Section of Medical Oncology, University of Palermo, Palermo, Italy.
Luca MoscettiAzienda Ospedaliero - Universitaria di Modena, Modena, Italy.
Maria Carmela PiccirilloClinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy.
Francesco PerroneClinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy.
Massimo Di MaioDipartimento di Oncologia, Università degli studi di Torino, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
Carmine PintoOncologia Medica, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Lorenza RimassaDepartment of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, Milan, Italy.
Roberto BordonaroDipartimento di Oncologia Medica - ARNAS Garibaldi di Catania, Catania, Italy.
Chiara CremoliniUnit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Gianmauro NumicoMedical Oncology Unit, AO S. Croce e Carle, Cuneo, Italy.
Alessandra FabiPrecision Medicine in Senology Unit, Department of Woman and Child Health and Public Health, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Giordano BerettaUOC Oncologia Medica Ospedale Pescara, Pescara, Italy.
Saverio CinieriMedical Oncology and Breast Unit, Ospedale Perrino di Brindisi, Brindisi, Italy.
Paolo TralongoAzienda Sanitaria Provinciale Siracusa Ospedale Umberto I via Testaferrata 1, 96100, Siracusa, Italy.
Paolo MarchettiDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167, Rome, Italy.
Luca BruneseDepartment of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, 86100, Campobasso, Italy.
Vittorio MieleDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Antonella PetrilloDivision of Radiology, "Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli", Naples, Italy.
Gianpaolo CarrafielloUniversity of Milan, Via Festa del Perdono 7, Milan, Italy.
Emanuele NeriDipartimento di Ricerca Traslazionale, Università di Pisa, Pisa, Italy.
Andrea GiovagnoniDepartment of Radiological Sciences - Division of Clinical Radiology, University Hospital Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy.
Luca Maria SconfienzaDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
Annarita LariciDepartment of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore di Roma, Rome, Italy.
Carlo CatalanoDepartment of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
Andrea LaghiDepartment of Biomedical Sciences, Humanitas University, 20072, Pieve Emanuele, Milan, Italy.
Stefania MontemezziIRCCS Sacrocuore Don Calabria Negrar di Valpolicella, Verona, Italy.
Silvia MagnaldiCentro Medico Esperia - Porcia, Pordenone, Italy.
Rossana BerardiDipartimento di Oncologia, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
Mirko D'OnofrioDipartimento di Diagnostica per Immagini, AOU Integrata di Verona, Università di Verona, Verona, Italy.
Roberto GrassiDipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.
Nicola Silvestris *Medical Oncology Unit - IRCCS Istituto Tumori "Giovanni Paolo II" - Bari, Bari, Italy.
Nicoletta Gandolfo *Diagnostic Imaging Department, Villa Scassi Hospital IRCCS-AOM, Genoa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultidisciplinary management of oncological patients has improved patient outcomes, responding effectively and efficiently to the patient's health needs. A critical element remains adequate communication, also between radiologist and oncologist, which promotes correct patient management. The Italian Society of Medical Oncology (AIOM) and the Italian Society of Medical and Interventional Radiology (SIRM) have created a working group of representative members to improve not only communication between the two categories but, above all, to allow each member of the different categories to benefit from guidelines of good clinical practice both for filling out the examination request form than the radiological report, and therefore, also allowing clinicians and radiologists who do not work in reference centers, to correctly manage patients in the various phases of their oncological path. MATERIALS AND

methodsA panel of expert oncologists (AIOM members) and radiologists (SIRM members) was established. Multi-round consensus-building Delphi exercise was performed to create a comprehensive structured report (SR) template and a comprehensive requesting model for computed tomography (CT). The requesting model was divided into six sections: (a) oncological family history; (b) relevant clinical data; (c) staging; (d) re-staging; (e) other reason; and (f) follow-up. Regarding CT SR, 3 models were proposed: (1) for staging; (2) for treatment evaluation, and (3) for follow-up. CT SR in staging phase was divided into nine sections: (a) primary tumor; (b) lymph node metastases; (c) liver metastases; (d) lung metastases; (e) brain metastases; (f) other organs (incl. skeleton) metastases; (g) peritoneum; (h) incidental findings and complications; and (i) conclusion. CT SR in treatment evaluation phase was divided into ten sections: (a) primary tumor; (b) lymph node metastases; (c) liver metastases; (d) lung metastases; (e) brain metastases; (f) other organs (incl. skeleton) metastases; (g) peritoneum; (h) treatment-related complication; (i) incidental findings; and (l) conclusion. CT SR in follow-up phase was divided into six sections: (a) appearance of lesions; (b) node metastases; (c) liver lesions; (d) peritoneum; (e) incidental findings and complications; and (f) conclusion. Cronbach's alpha (Cα) correlation coefficient was used to evaluate internal consistency for each item and the quality analysis according to the average inter-item correlation. Each expert expressed individual comments for each specific template section by using a four-point scale (0 = strongly disagree, 1 = slightly disagree, 2 = modestly agree, 3 = strongly agree).

resultsWith regard to the 3 CT SR reports, at the first round, all sections achieved ratings above the "good" level. The staging items showing the highest level of agreement among experts in the first round were lung metastases and incidental findings and complications. For treatment evaluation, the items with the highest agreement were treatment-related complication and incidental findings. For follow-up, the items with the highest agreement were appearance of lesions and incidental findings and complications. At the first round, Cronbach's alpha (Cα) correlation coefficients were 0.92, 0.95, and 0.90 for staging, re-staging, and follow-up, respectively. At the second round, all sections achieved ratings at the "excellent" level. Regarding requesting model, at first round, all sections received an overall score equal to or greater than the level defined as "good" (score = 2). The item that showed the highest level of agreement in the first round was the follow-up section, with a mean value of 2.75 ± 0.62. The correlation coefficient, Cronbach's alpha (Cα), was 0.75. In the second round, for both the CT SR report and the oncologist request template, all elements received "excellent" ratings. During the inter-society agreement, six AIOM members assessed the CT SR model developed by SIRM, while six SIRM members evaluated the CT requesting model proposed by AIOM. In this single Delphi round, all participants assigned the maximum score (3) to every item across all sections.

conclusionsThe inter-society collaboration between AIOM and SIRM is a milestone in improving communication between radiologists and oncologists. The CT request and reporting documents meet the needs of quality care even outside of referral centers, and although do not represent an obligation, they can facilitate understanding between the different categories of professionals involved in patient management.

Indexed as

CommunicationComputed tomographyGood clinical practiceMultidisciplinary teamRadiological report

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.